Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production.
暂无分享,去创建一个
[1] B. Gómez,et al. Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture. , 2002, Virus research.
[2] J. Kimpen,et al. Novel pathways in the pathogenesis of respiratory syncytial virus disease , 2000, Pediatric pulmonology.
[3] L. Larsen,et al. Bovine Respiratory Syncytial Virus (BRSV): A review , 2000, Acta Veterinaria Scandinavica.
[4] Zili Jiang,et al. Autocrine regulation of interleukin‐8 by interleukin‐1α in respiratory syncytial virus‐infected pulmonary epithelial cells in vitro , 1998, Immunology.
[5] H. Ochiai,et al. Contribution of tumor necrosis factor α and interleukin‐1 α on the production of macrophage inflammatory protein‐2 in response to respiratory syncytial virus infection in a murine macrophage cell line, RAW264.7 , 1997, Journal of medical virology.
[6] H. Tsutsumi,et al. Enhanced cytokine production by milk macrophages following infection with respiratory syncytial virus , 1997, Journal of leukocyte biology.
[7] A. Stadnyk,et al. Respiratory syncytial virus triggers synthesis of IL-6 in BALB/c mouse alveolar macrophages in the absence of virus replication. , 1997, Cellular immunology.
[8] J. Kimpen. Respiratory syncytial virus immunology , 1996, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[9] J. Goding. 9 – Purification, Fragmentation and Isotopic Labelling of Monoclonal Antibodies , 1996 .
[10] L. Kobzik,et al. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. , 1995, Journal of immunology.
[11] P. Cane,et al. Molecular epidemiology of respiratory syncytial virus: A review of the use of reverse transcription‐polymerase chain reaction in the analysis of genetic variability , 1995, Electrophoresis.
[12] M. Lohmann‐Matthes,et al. Interaction of alveolar macrophages and respiratory syncytial virus. , 1994, Journal of immunological methods.
[13] T. Molitor,et al. Interaction of bovine respiratory syncytial virus with bovine alveolar macrophages in vivo: effects of virus infection upon selected cell functions. , 1994, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[14] J. Kolls,et al. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. , 1993, The Journal of infectious diseases.
[15] P. Payment,et al. Methods and techniques in virology , 1993 .
[16] A. Villani,et al. Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients. , 1992, The American review of respiratory disease.
[17] S. Becker,et al. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. , 1991, Journal of immunology.
[18] P. Cane,et al. Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). , 1991, The Journal of general virology.
[19] E. R. Mcfadden,et al. Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2. , 1990, The American journal of physiology.
[20] E. R. Mcfadden,et al. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. , 1990, The Journal of clinical investigation.
[21] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[22] J. Goding,et al. Monoclonal Antibodies: Principles and Practice , 1996 .
[23] C. Bangham,et al. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[24] N. Roberts,et al. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity , 1986, The Journal of experimental medicine.
[25] Z. Cohn,et al. The alveolar macrophage. , 1986, Journal of applied physiology.
[26] T. Jungi. A rapid and sensitive method allowing photometric determination of erythrophagocytosis by mononuclear phagocytes. , 1985, Journal of immunological methods.
[27] C. Hall,et al. Respiratory Syncytial Virus , 1983 .
[28] J. Gerin,et al. The Development of Balb/c Cells Persistently Infected with Respiratory Syncytial Virus: Presence of Ribonucleoprotein on the Cell Surface 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[29] G. Gifford,et al. Rabbit tumor necrosis factor: mechanism of action , 1981, Infection and immunity.
[30] J. Unkeless. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.
[31] P. Malloy,et al. Initiation and maintenance of persistent infection by respiratory syncytial virus , 1978, Journal of virology.
[32] R. Dreizin,et al. [Chronic infection of HeLa cells with respiratory syncytial virus]. , 1977, Voprosy virusologii.
[33] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[34] L. Senterfit,et al. Persistent Infection of Cells in Culture by Respiratory Syncytial Virus , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[35] H. Koren,et al. Identification of macrophage-like characteristics in a cultured murine tumor line. , 1975, Journal of immunology.
[36] J. Melnick,et al. Au-antigen particles. , 1970, Lancet.
[37] R. Chanock,et al. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. , 1969, American journal of epidemiology.
[38] R. Chanock,et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.